Intrinsiqs

Is Cabaletta Bio, Inc. overvalued?

Cabaletta Bio, Inc. (CABA) — key valuation metrics and fundamentals.

No verdict
Price
$1.28
Fair value
—
Current P/E
—
Normal P/E
—
Market cap
$276.1M
Dividend yield
0.0%
Return on equity
-106.8%
Sector
Healthcare

See the full interactive analysis →

Fair value compares CABA's current P/E to its own historical "normal" P/E (FAST Graphs-style). Updated 12 Nov 2026.